Back

Different loop diuretic dosing and administration in acute Heart Failure (DIUR-AHF): effects on congestion renal function and outcome

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Diuretic treatment and decongestion Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Associate Professor Alberto Palazzuoli

University of Siena, Siena (Italy)

5 More presentations in this session

Presentation thumbnail
Clinical characteristics and predictors of successful decongestion in patients with acute heart failure: data from the nationwide BRING-UP3 HF study
Doctor C. Basile (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Factors associated with a higher diuretic response in acute heart failure (AHF): a post-hoc analysis of the CLOROTIC trial
Doctor J. Morales Rull (Lleida, ES)
Abstract Slides Video
Presentation thumbnail
Impact of initial furosemide dosing on hospitalization and 1-year mortality in acute heart failure
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Outcomes of urine sodium guided diuresis in acute heart failure: a preliminary analysis
Ms C. Chua (Kuching, MY)
Abstract Slides Video
Presentation thumbnail
The role of acetazolamide in enhancing diuresis in acute decompensated heart failure: insights from a real-world retrospective cohort study
Mrs A. Freitas (Curitiba, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Diuretic treatment and decongestion

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Loop diuretic use before an acute heart failure hospitalization drives natriuretic response but not the efficacy of natriuresis-guided diuretic therapy, a prespecified analysis from the PUSH-AHF trial
thumbnail
Congress Presentation
Deprescribing loop diuretics in very old patients with heart failure: clinical phenotype and safety
thumbnail
Congress Session
Late breaking clinical trials: medical therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources